| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| car-gpc3 t cells | glypican-3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lung[MeSHID:D008168] T-Lymphocyte[MeSHID:D013601] Squamous cell carcinoma[MeSHID:D002294] |
NA | clinical trial | unknown |
| car-gpc3 t cells | glypican-3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] T-Lymphocyte[MeSHID:D013601] Liver carcinoma[MeSHID:D006528] |
NA | phase 1 | unknown |
| car-gpc3 t cells | glypican-3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lung[MeSHID:D008168] T-Lymphocyte[MeSHID:D013601] Squamous cell carcinoma[MeSHID:D002294] |
NA | phase 1 | unknown |
| car-gpc3 t cells | glypican-3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] T-Lymphocyte[MeSHID:D013601] Liver carcinoma[MeSHID:D006528] |
NA | clinical trial | unknown |
| click here to return to the previous page | ||||||||